Anavex Life Sciences Corp (AVXL)

[DP56]

As a long term Avenex investor (first time poster on this board), I'll admit yesterday was certainly frustrating, but I choose to focus my attention on a finding from the study that I don't think is getting the attention it deserves.

Any trial medication (that has minimal side effects) that can reduce the frequency of seizures by 50% will eventually be approved.

For that reason alone (and there are certainly other good reasons), the Rett Syndrome caregivers and medical providers will not stop advocating until it is approved.

It is just a matter of time.